This content was excerpted from EyeNet’s MIPS 2018; also see the Academy’s MIPS hub page.
What’s New in Quality
Here are some of the biggest changes to MIPS quality reporting.
Reduced contribution to final score. The quality performance category now contributes up to 50 points to your MIPS final score (down from 60 points in 2017).
Report 1 year of data. The performance period for quality is now the full calendar year (up from 90 days in 2017).
Report on more patients. The data completeness criteria is now 60% of applicable patients for each measure (up from 50% in 2017).
For large practices, quality measures now have a floor of 1 point. If you don’t meet the data completeness criteria for a measure, and you are reporting as part of a large practice, you will score 1 point (down from 3 points in 2017); if reporting as part of a small practice, you will score 3 points (same as last year).
More measures available for automated reporting via IRIS Registry/EHR integration. You can now report 17 of the ophthalmology-specific QCDR measures via IRIS Registry/ EHR integration, but only if the IRIS Registry is able to extract the relevant data from your EHR system. However, these measures do not yet have benchmarks, so points may be limited unless CMS is able to establish a benchmark using 2018 reported data. Review at-a-glance tables (PDF) of both the standard (Table 11) and QCDR (Table 12) quality measures that can be reported via the IRIS Registry, or browse those measures online.
Six topped out measures now have a ceiling of 7 points. Most of these measures aren’t relevant to ophthalmology, but 1 of them might be used by some ophthalmology practices— measure 224: Melanoma: Overutilization of Imaging Studies in Melanoma.
A new bonus for improved performance. If you reported the quality performance category in 2017, you may be able to score points for improved performance in 2018.
Previous: What's New: Low-Volume Threshold Went Up; Practice Size Is Now Based on Historic Data.
Next: What’s New for Promoting Interoperability (Formerly Advancing Care Information).
Note: Meeting regulatory requirements is a complicated process involving continually changing rules and the application of judgment to factual situations. The Academy does not guarantee or warrant that regulators and public or private payers will agree with the Academy’s information or recommendations. The Academy shall not be liable to you or any other party to any extent whatsoever for errors in, or omissions from, any such information provided by the Academy, its employees, agents, or representatives.
COPYRIGHT© 2018, American Academy of Ophthalmology, Inc.® All rights reserved. No part of this publication may be reproduced without written permission from the publisher. American Academy of Ophthalmic Executives® and IRIS® Registry are trademarks of the American Academy of Ophthalmology®.